Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics

Etiology of Cardiovascular Complications in HIV Infection
Endothelial Dysfunction in HIV Infection
Cardiovascular Complications from Cocaine Abuse in HIV Infection
Genesis of Cardiomyopathy with HIV Infection and Alcohol Abuse

May 2-3, 2002


[Meeting Summary], [Recommendations], [Roster]

Agenda

Thursday, May 2, 2002

8:00 a.m. Registration and Poster Setup
8:30 a.m. Welcome and Introduction
Lan-Hsiang Wang, NHLBI
Jag Khalsa, NIDA
Sandra Colombini Hatch, NHLBI
8:40 a.m. Lance Terada (1)
University of Texas Southwestern
Effect of HIV Tat on Endothelial Cell Function
9:00 a.m. Mitchell Finkel (16)
West Virginia University
P38 MAP Kinase Regulates Negative Inotropic Effect of HIV gp120 on Cardiac Myocytes through Troponin I Phosphorylation
9:20 a.m. Jian-Feng Wang (3)
Beth Israel Deaconess Medical Center
Functional Studies of HIV-Tat Effects on Endothelium
9:40 a.m. Winnie Henderson (4)
Oregon Health Sciences University
HIV-1 vpu and tat Modulate Endothelial Cell-B Lymphoma Cell Interactions:
Implications for AIDS-Associated Non-Hodgkin's Lymphoma
10:00 a.m. Break
10:20 a.m. John Ho (5)
Cornell University
HIV-1 Activates Innate Immune Cells via Toll-Like Receptor 2
10:40 a.m. Emily D. Overholser (6)
Johns Hopkins University
Mechanisms of Endothelial Cell Dysfunction in SIV Infection
11:00 a.m. Lingjun Zhao (7)
Saint Louis University Medical Center
Regulation of Myosin Light Chain Phosphorylation by HIV-1 Vpr
11:20 a.m. Changyi Chen (8)
Baylor College of Medicine
HIV-1 gp120 Down-Regulates Endothelial Nitric Oxide Synthase (eNOS) Expression in Human Endothelial Cells
11:40 a.m. Kwang Sik Kim (9)
Johns Hopkins University
Gp120 Induces Cytotoxicity of Human Brain Microvascular Endothelial Cells
12:00 p.m. Lunch
1:00 p.m. Poster Session (Atrium)
Posters will be displayed from 8:30 a.m. until 5 p.m.
Poster presenters with odd numbers will be present from 1 p.m. to 1:50 p.m.
Poster presenters with even numbers will be present from 1:50 p.m. to 2:40 p.m.

Harris McFerrin (2)--poster presentation only
Tulane University
Molecular Mechanism of Tat-Induced Angiogenesis
2:40 p.m. Break
3:00 p.m. Douglas Larson (10)
University of Arizona
Dilated Cardiomyopathy in Murine Acquired Immunodeficiency Syndrome (MAIDS)
3:20 p.m. Ronald Watson (11)
University of Arizona
Selenium Supplementation Decreases Coxsackievirus Heart Disease During Murine AIDS
3:40 p.m. J. Bruce Sundstrom (12)
Emory University
An in vitro Model for Investigating the Role of Mast Cells in Mechanisms of Increased Fibrosis Associated with AIDS-Related Cardiomyopathies
4:00 p.m. Debasis Mondal (13)
Tulane University
Synergistic Effects of Cocaine and the Inflammatory Cytokines in Modulating Vascular Endothelial Cell Function
4:20 p.m. Guha Krishnaswamy (14)
East Tennessee State University
Role of the Inflammatory Network in Cocaine and HIV-Mediated Atherogenesis
4:40 p.m. Shenghan Lai (17)
Johns Hopkins University
Association of Cocaine Use With Coronary Calcification in Injecting Drug Users in Baltimore
5:00 p.m. Recommendations for Future Directions Ronald Watson
5:20 p.m. Conclusion of Today's Program
5:20 - 5:40 p.m. Remove posters from poster boards

Friday, May 3, 2002

8:30 a.m. Milan Fiala (15)
University of California Los Angeles
(A) Human Immunodeficiency Virus Type 1 Enters Brain and Coronary Endothelia by Macropinocytosis Dependent upon Lipid Rafts.
(B) Cocaine Binds to a G-Protein Coupled Receptor, Signals and Restructures Coronary Artery Endothelial Cells.
8:50 a.m. John Bauer (18)
Ohio State University
Cocaine Induced Cardiotoxicity in Mice
9:10 a.m. Roy Sutliff (19)
Emory University
Cocaine Administration Increases LV Mass in HIV-1 Transgenic Mice
9:30 a.m. Sonia Flores (20)
University of Colorado
Evidence of Inflammation in Tat-Transgenic Mice
9:50 a.m. John Bauer (21)
Ohio State University
Mechanistic Studies of Retrovirus Related Cardiac Dysfunction: the Murine AIDS Model and Human HIV Infection
10:10 a.m. Douglas Wallace (22)
Emory University
Ethanol and AIDS Cardiomyopathy: A Mitochondrial Connection?
10:30 a.m. Break
10:50 a.m. Paul Jolicoeur (23)
Clinical Research Institute of Montreal
Studies of Cardiac Disease in HIV-1 Transgenic Mice
11:10 a.m. William Lewis (24)
Emory University
Combined Antiretroviral Therapy Causes Cardiomyopathy and Elevates Plasma Lactate in Transgenic AIDS Mice
11:30 a.m. Richard Shannon (25)
New England Regional Primate Research Center
Cellular Pathways Involved in Myocardial Injury in Simian AIDS: Role of Cytokines, Inducible Nitric Oxide, and CD95
11:50 a.m. Milan Fiala (26)
University of California Los Angeles
HIV-1 Envelope Protein gp120 Induces Cardiomyocyte Apoptosis and Is Associated with HIV-1 Cardiomyopathy
12:10 a.m. Neil Bowles (27)
Baylor College of Medicine
The Pathogenesis of Heart Disease in HIV-Infected Children
12:30 p.m. Closing Remarks
12:40 p.m. Adjournment Of Meeting



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Thursday, July 25, 2002. The U.S. government's official web portal